miR-204-5p in vivo inhibition cause diminished CD45RO cells rate in lungs of melanoma B16-bearing mice.
Apoptosis
CD45RO
Melanoma B16
miR-204-5p
miR-211
microRNA LNA inhibitor
Journal
Non-coding RNA research
ISSN: 2468-0540
Titre abrégé: Noncoding RNA Res
Pays: Netherlands
ID NLM: 101688191
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
12
03
2022
revised:
31
05
2022
accepted:
01
06
2022
entrez:
27
6
2022
pubmed:
28
6
2022
medline:
28
6
2022
Statut:
epublish
Résumé
The treatment of melanoma remains a challenge, despite novel approaches recently becoming available for disseminated tumors. RNA targeting is being intensively studied in various types of disease. The aim of the present study was to explore whether the in vivo use of a microRNA (miR)-204-5p inhibitor affected melanoma progression, and whether its metastasis affects target organ remodeling. CD45RO
Identifiants
pubmed: 35756165
doi: 10.1016/j.ncrna.2022.06.001
pii: S2468-0540(22)00031-2
pmc: PMC9188961
doi:
Types de publication
Journal Article
Langues
eng
Pagination
133-141Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
None.
Références
Oncotarget. 2017 Apr 11;8(15):25395-25417
pubmed: 28445987
JCI Insight. 2019 Mar 21;4(6):
pubmed: 30721153
Cancer Res. 2018 Jun 15;78(12):3122-3134
pubmed: 29610116
Nat Commun. 2016 Sep 15;7:12819
pubmed: 27628423
Stem Cells Int. 2020 Mar 16;2020:1540905
pubmed: 32256607
Cancer Lett. 2007 Sep 8;254(2):157-64
pubmed: 17306454
N Engl J Med. 2019 Oct 17;381(16):1535-1546
pubmed: 31562797
Sci Rep. 2015 May 21;5:10501
pubmed: 25994622
Oncogene. 2011 Mar 24;30(12):1481-8
pubmed: 21102518
PLoS One. 2016 Dec 22;11(12):e0168229
pubmed: 28005927
Front Oncol. 2020 Feb 27;10:220
pubmed: 32175277
Mod Pathol. 2014 Sep;27(9):1193-202
pubmed: 24434899
Int J Mol Sci. 2020 Aug 31;21(17):
pubmed: 32878032
J Cancer Res Clin Oncol. 2013 Jan;139(1):57-65
pubmed: 22903384
Cancer Res. 2019 Apr 1;79(7):1520-1534
pubmed: 30737233
J Pharmacol Sci. 2020 Jun;143(2):122-126
pubmed: 32199747
Int Immunopharmacol. 2021 May;94:107470
pubmed: 33640856
J Mol Endocrinol. 2019 Aug;63(2):139-149
pubmed: 31277072
N Engl J Med. 2019 Aug 15;381(7):626-636
pubmed: 31166680
J Hum Genet. 2018 Dec;63(12):1197-1210
pubmed: 30228364
Oncogene. 2010 Feb 18;29(7):937-48
pubmed: 19935707
Horm Behav. 2015 Jul;73:64-74
pubmed: 26143620
Biol Open. 2020 Nov 6;9(11):
pubmed: 33037013
Mol Cancer. 2016 Jul 25;15(1):53
pubmed: 27457246
J Invest Dermatol. 2021 Jan;141(1):23-31
pubmed: 32268150
Nucleic Acids Res. 2008 Mar;36(4):1153-62
pubmed: 18158304
Methods Mol Biol. 2014;1070:131-40
pubmed: 24092437
J Biol Chem. 2003 Jul 4;278(27):24849-57
pubmed: 12676959
Acta Neurobiol Exp (Wars). 2014;74(4):424-32
pubmed: 25576973
Nat Commun. 2017 Apr 10;8:15016
pubmed: 28393839
Oncol Lett. 2018 Jun;15(6):8269-8280
pubmed: 29844810
Cancer Lett. 2017 Aug 28;402:1-8
pubmed: 28536008
Expert Rev Mol Med. 2009 Mar 23;11:e10
pubmed: 19302730
Mol Oncol. 2022 Feb;16(3):565-593
pubmed: 34080276
Proc Natl Acad Sci U S A. 2015 Jun 23;112(25):E3236-45
pubmed: 26056285
Cancer Discov. 2021 Apr;11(4):971-994
pubmed: 33811127
J Immunol. 1996 Apr 15;156(8):2743-53
pubmed: 8609392
Eur J Immunol. 2016 Jun;46(6):1490-503
pubmed: 27005442
Oncol Lett. 2019 May;17(5):4155-4161
pubmed: 30944610
N Engl J Med. 2018 Jul 5;379(1):11-21
pubmed: 29972753
Oncotarget. 2012 Apr;3(4):365-70
pubmed: 22562943
Int J Nanomedicine. 2016 Jul 28;11:3533-44
pubmed: 27555773
Clin Exp Immunol. 2002 Jul;129(1):78-85
pubmed: 12100025
Open Virol J. 2009 Apr 01;3:21-5
pubmed: 19572053
Nature. 2018 Aug;560(7718):291-292
pubmed: 30108348
Cell Death Differ. 2015 May;22(5):815-25
pubmed: 25342468
Blood. 2005 Apr 15;105(8):3295-302
pubmed: 15626731
Br J Cancer. 2012 Sep 4;107(6):967-76
pubmed: 22892391
Mol Cancer. 2018 Mar 9;17(1):71
pubmed: 29523154
Noncoding RNA. 2021 Apr 16;7(2):
pubmed: 33923485
Melanoma Res. 2017 Feb;27(1):8-16
pubmed: 27776018
Front Cell Dev Biol. 2020 Oct 08;8:568366
pubmed: 33117799
J Exp Med. 1996 Apr 1;183(4):1707-18
pubmed: 8666928
Cell Div. 2019 Oct 10;14:11
pubmed: 31624492
Biomedicines. 2021 May 03;9(5):
pubmed: 34063675
Int J Mol Sci. 2021 Feb 03;22(4):
pubmed: 33546502